Loading clinical trials...
Loading clinical trials...
A Randomized, Positive Controlled Trial That Assess the Safety And Efficacy of Umbilical Cord-Derived Mesenchymal Stem Cells in Moderate and Severe Plaque Psoriasis Patients
Conditions
Interventions
Low-dose UC-MSCs
High-dose UC-MSCs
+1 more
Locations
2
China
Peking University Third Hospital
Beijing, China
Tianjin Ever Union Biotechnology Co., Ltd.
Beijing, China
Start Date
June 1, 2018
Primary Completion Date
September 30, 2018
Completion Date
December 31, 2019
Last Updated
April 20, 2018
Lead Sponsor
Tianjin Ever Union Biotechnology Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions